Displaying 1 to 20 of 35 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Acorda Therapeutics Inc A biotechnology company whose mission is to develop and market therapeutic products for spinal cord injury and other central nervous system disorders. |
United States | N/A Initial investment. Round participant. Active |
||
|
Aderis Pharmaceuticals Inc Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Alexza Pharmaceuticals Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Alveolus Inc |
United States | N/A Active |
||
|
|
Archemix Corp A biotechnology company, engages in discovering, developing, and commercializing aptamer therapeutics for the treatment of life threatening diseases. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Argos Therapeutics Inc |
United States | 1 Apr 2008 | Series C Initial investment. Round participant. Active |
|
|
|
Argos Therapeutics Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Argos Therapeutics Inc |
United States | 1 Apr 2012 | Series D Follow-on investment. Round participant. Active |
|
|
|
Avalon Pharmaceuticals Inc Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
BaroNova Inc Developer of non-surgical devices to induce weight loss |
United States | 23 Nov 2015 | Series D Follow-on investment. Round participant. Active |
|
|
|
BaroNova Inc Developer of non-surgical devices to induce weight loss |
United States | 15 Feb 2013 | Series C Initial investment. Round participant. Active |
|
|
|
Cardiac Dimensions Inc Medical device company developing novel interventional tools for the treatment of heart failure & the related condition of mitral valve regurgitation. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Cardiovascular Systems Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Ception Therapeutics Inc Ception Therapeutics, Inc. is an emerging biopharmaceutical company. |
United States | N/A Active |
||
|
|
Corus Pharma Inc A specialty pharmaceutical development company developing and obtaining regulatory approvals of products for respiratory and infectious diseases. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
DC Devices Inc Developer of medical equipment used in the treatment of heart failure |
United States | 18 Mar 2013 | Venture Initial investment. Round participant. Active |
|
|
|
DepoMed Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Guava Technologies Inc A biotechnology company providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Immunicon Corp Biotechnology company specializing in cell-based research and diagnostic products with an initial focus on cancer. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Inovise Medical Inc Diagnostic medical technology company that is shaping cardiac care worldwide. |
United States | N/A Initial investment. Round participant. Active |